Sotera Health Company (SHC) exhibits 55.5% gross margins and 3.1% return on invested capital within Health Care (Misc Health and Biotechnology Services), balanced against a 33.5x enterprise multiple and 7.2% implied options volatility.
Sustained 55.5% gross profitability converts into 8.2% operating margin and 3.1% ROIC, outpacing sector cost of capital.
ROIC: 3.1% // GM: 55.5%YoY revenue trajectory of +5.7% paired with 2.80% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +5.7% // FCF YLD: 2.80%Altman Z-Score of 1.56 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.56 // F-SCORE: 8/9Trading at 68.5x trailing P/E (63.7x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 68.5x // EV/EBITDA: 33.5xOptions market prices a ±7.2% implied move with a 0.92 put/call ratio around $18.00 max pain.
IMPL MOVE: ±7.2% // P/C: 0.92Elevated industry capital intensity and customer concentration in Misc Health and Biotechnology Services require continuous execution to defend 6.7% net margins.
NET MARGIN: 6.7% // D/E: 3.51x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for SHC & activate live FRED threshold breach alerts.